Polar Asset Management Partners Inc.
Position in SLXN — Silexion Therapeutics Corp
CIK 1326389
TORONTO, A6
Position in SLXN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
743,475
0.0% QoQ
Ownership
13.4%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLXN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Polar Asset Management Partners Inc. holds $46,847,679 across 12 Biotechnology names. SLXN ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 322,467 | $42,801,044 | |||
| 2 | RNA |
Atrium Therapeutics, Inc.
|
150,000 | $2,017,500 | |
| 3 | RANI |
Rani Therapeutics Holdings, Inc.
|
2,318,542 | $1,762,091 | |
| 4 | EXEL |
Exelixis, Inc.
|
4,908 | $267,044 | |
| 5 | 1,150,300 | $0 | |||
| 6 | 320,529 | $0 | |||
| 7 | OSRH |
OSR Health, Inc.
|
360,000 | $0 | |
| 8 | TVGN |
Tevogen Inc.
|
700,000 | $0 |
No Holdings History
No holdings records found for this institution in SLXN.